Pilot Trial of Autologous Tumor Infiltrating Lymphocytes (LN-144) for Patients With Metastatic Uveal Melanoma

Conditions:   Uveal Melanoma;   Melanoma;   Metastatic Uveal Melanoma;   Metastatic Melanoma Intervention:   Biological: Lifileucel (LN-144) Sponsors:   Memorial Sloan Kettering Cancer Center;   Iovance Biotherapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials